Biocon Malaysia arm gets UK regulator approval for Semglee fill finish unit

Biocon Ltd. on Friday, September 25, said its Malaysia arm received approval from the UK drug regulator for its new drug product fill finish unit for Semglee (insulin glargine) at its insulin manufacturing facility in Malaysia.The company said the Medicines and Healthcare Products Regulatory Agency…